Trials / Completed
CompletedNCT01652339
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To assess the pharmacokinetic characteristics of Lodivixx tab.5/160mg in healthy male subjects * PK parameter evaluation * Safety profile evaluation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exforge tab. 10/160mg | |
| DRUG | Lodivixx tab. 5/160mg |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-08-01
- Completion
- 2012-12-01
- First posted
- 2012-07-30
- Last updated
- 2013-03-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01652339. Inclusion in this directory is not an endorsement.